1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Chronic Lung Injury in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gu, X; Jiao, Y; Liu, M; Ma, Z; Qi, M; Shi, X; Xie, X; Zhang, T; Zhou, L | 1 |
Cassali, GD; Fagundes, CT; Garcia, CC; Guabiraba, R; Machado, AV; Polidoro, RB; Russo, RC; Salgado, AP; Sousa, LP; Tavares, LP; Teixeira, MM | 1 |
Bancalari, E; Huang, J; Rodriguez, MM; Smalling, WE; Suguihara, C | 1 |
Bugelski, PJ; Esser, KM; Feuerstein, G; Hillegass, LM; Rabinovici, R; Vernick, J | 1 |
Hugli, TE; Piccolo, MS; Piccolo, MT; Piccolo, NS; Sannomiya, P; Till, GO; Wang, Y; Ward, PA | 1 |
Kitsiouli, EI; Lekka, ME; Nakos, G | 1 |
Kelly, RF | 1 |
Ono, S; Voelkel, NF | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chronic Lung Injury
Article | Year |
---|---|
Current strategies in lung preservation.
Topics: Animals; Antioxidants; Cold Temperature; Cyclic AMP; Cyclic GMP; Free Radical Scavengers; History, 20th Century; Humans; Lung; Lung Injury; Lung Transplantation; Organ Preservation; Platelet Activating Factor; Reperfusion Injury; Respiration, Artificial; Solutions; Vasodilator Agents | 2000 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chronic Lung Injury
Article | Year |
---|---|
Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis.
Topics: Animals; Dinoprostone; Extracellular Traps; Immunoglobulin Class Switching; Lung Injury; Macrophages; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Sepsis | 2023 |
Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.
Topics: Animals; Apoptosis; Blotting, Western; Chickens; Dihydropyridines; Disease Models, Animal; Inflammation Mediators; Influenza A Virus, H1N1 Subtype; Lung Injury; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Orthomyxoviridae Infections; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Toll-Like Receptors; Viral Load | 2010 |
Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Biomechanical Phenomena; Inflammation; Lung; Lung Diseases; Lung Injury; Pentoxifylline; Peroxidase; Placebos; Platelet Activating Factor; Respiration, Artificial; Swine; Thromboxane B2; Tidal Volume | 2004 |
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.
Topics: Animals; Disease Models, Animal; Endotoxins; Hemodynamics; Lipopolysaccharides; Lung; Lung Injury; Male; Microscopy, Electron; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Thromboxane B2; Tumor Necrosis Factor-alpha | 1993 |
Chemotactic mediator requirements in lung injury following skin burns in rats.
Topics: Animals; Antibodies, Blocking; Bronchoalveolar Lavage Fluid; Burns; Capillary Permeability; Chemokine CXCL2; Chemokines; Chemotactic Factors; Chemotaxis, Leukocyte; Complement C5a; Cytokines; Interleukin-1; Lung; Lung Diseases; Lung Injury; Male; Monokines; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Rats; Rats, Long-Evans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Tumor Necrosis Factor-alpha | 1999 |
Differential determination of phospholipase A(2) and PAF-acetylhydrolase in biological fluids using fluorescent substrates.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; 4-Chloro-7-nitrobenzofurazan; Animals; Body Fluids; Bronchoalveolar Lavage Fluid; Calcium; Fatty Acids; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Kinetics; Lung; Lung Injury; Pancreas; Phosphatidylcholines; Phospholipases A; Platelet Activating Factor; Reference Standards; Serum Albumin, Bovine; Sonication; Spectrometry, Fluorescence; Substrate Specificity; Swine; Temperature | 1999 |
PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
Topics: Animals; Azepines; Cardiomegaly; Hypertension, Pulmonary; Lung; Lung Injury; Male; Monocrotaline; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles | 1991 |